Synopsys (SNPS) Margin Compression And 119x P/E Test Bullish Earnings Narratives

Synopsys (SNPS) has just posted Q2 2026 results with revenue of about US$2.3 billion and basic EPS of US$0.09, set against a trailing 12 month EPS of US$4.25 and net income of US$773.3 million as the stock trades around US$480.64. Over the past six reported quarters, revenue has moved from US$1.46 billion in Q1 2025 to roughly US$2.28 billion in Q2 2026. Quarterly basic EPS has ranged from US$1.51 to US$2.42 in 2025, then came in at US$0.34 in Q1 2026 and US$0.09 in the latest quarter. With analysts watching earnings trends and margins currently tracking below the prior year, this set of numbers places profitability and its trajectory in clear focus for investors.

See our full analysis for Synopsys.

With the figures on the table, the next step is to see how these earnings and margin trends line up with the prevailing narratives around Synopsys and where those stories might need updating.

See what the community is saying about Synopsys

Margins Compress With 8.9% Net Profit

• Trailing 12 month net profit margin sits at 8.9%, compared with 21.7% in the prior year, on about US$8.7b of revenue and US$773.3m of net income.
• Consensus narrative expects higher value IP and SaaS offerings to support margin strength over time, yet the recent margin level and Q2 2026 net income of US$17.1m highlight the tension between that expectation and the current profitability profile.
  • Analysts see margin potential in the shift toward integrated EDA, IP, and cloud delivery. However, the trailing margin and basic EPS of US$0.09 this quarter show that earnings are currently running below those longer term ambitions.
  • Geopolitical pressure and business transition costs mentioned in the consensus view fit with the lower 8.9% net margin, which contrasts with the higher profitability implied by the expansion into more complex, higher value sectors.

One Off US$313.5m Gain Distorts Trailing Earnings

• The trailing 12 month figures include a US$313.5m one off gain, which affects how the US$773.3m of net income and US$4.25 of trailing EPS read against the much lower Q2 2026 basic EPS of US$0.09.
• Consensus narrative points to acquisitions and product integration as growth drivers, and the presence of a large non recurring gain means you need to separate ongoing earnings power from items tied to portfolio reshaping.
  • The integration of Ansys and related portfolio moves identified in the consensus view help explain why one off items appear in the trailing numbers. At the same time, they make it harder to use recent EPS alone as a guide to underlying performance.
  • Analysts expecting earnings growth over time need to consider the gap between the US$4.25 trailing EPS (inflated by the one off) and the latest US$0.09 quarterly EPS, which underlines why adjusting for that US$313.5m gain is important when weighing that story.

Premium 119x P/E Sets A High Bar

• At a share price of about US$480.64, Synopsys trades on a trailing P/E of roughly 119x, well above the US software industry average of 28.5x and a peer average of 34.6x.
• Analysts' consensus view links this premium to growth in complex EDA and simulation markets. However, the current 119x P/E and 8.9% trailing net margin mean the stock is priced well above sector norms while profitability metrics sit below the prior year.
  • The consensus narrative highlights expansion into sectors like automotive and aerospace, but the high multiple leaves limited room for disappointment if margin trends or earnings growth do not track the expectations reflected in that price.
  • Customer concentration, export limitations, and integration costs flagged in the consensus view become more important risk factors when the valuation already stands far above the industry and peer P/E benchmarks.

If you want to see how other investors are weighing these growth expectations against valuation and risk, the community narratives pull these numbers together in one place, so you can compare different storylines side by side before you decide what they mean for you. 📊 Read the what the Community is saying about Synopsys.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Synopsys on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

With sentiment in this article pulling in both cautious and optimistic directions, it may be useful to move quickly and test the story against the numbers yourself using our breakdown of 1 key reward and 3 important warning signs

See What Else Is Out There

Synopsys is contending with compressed net margins, a very high 119x P/E, and quarterly EPS that sits well below its trailing 12 month figure.

If those pressures make you want something priced more reasonably relative to earnings and quality, check out the 46 high quality undervalued stocks to quickly spot stocks where fundamentals and valuation look better aligned.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com